Elexacaftor CAS No.:2216712-66-0

Introduction:

Elexacaftor CAS No.:2216712-66-0 is a breakthrough product for treating cystic fibrosis, which has been designed and manufactured by our company. The product has been widely accepted and appreciated by the medical community for its effectiveness in treating cystic fibrosis. The product has also received many positive reviews from users who have experienced relief from the symptoms of cystic fibrosis.

What is Cystic Fibrosis?

Cystic fibrosis is a hereditary disease that affects the mucus and sweat glands in the body, leading to the accumulation of thick, sticky mucus in the lungs, digestive system, and other organs in the body. This can cause various symptoms such as breathing difficulties, chest infections, digestive problems, nasal congestion, and more. Cystic fibrosis is a chronic disease with no known cure, but there are treatments available that can alleviate the symptoms and improve the quality of life for patients.

The Role Of Elexacaftor CAS No.:2216712-66-0 In Treating Cystic Fibrosis:

Elexacaftor CAS No.:2216712-66-0 is a medicine that is designed to target and treat the underlying cause of cystic fibrosis. The medicine works by improving the function of the CFTR protein, which is responsible for regulating the flow of salt and water in and out of the cells. In people with cystic fibrosis, the CFTR protein is defective, leading to the accumulation of thick, sticky mucus in the lungs, digestive system, and other organs.

Elexacaftor CAS No.:2216712-66-0 works by improving the function of the CFTR protein, which allows the mucus in the lungs to become thinner and easier to clear. This can reduce the risk of lung infections, improve lung function, and improve the quality of life for patients with cystic fibrosis.

Why Choose Elexacaftor CAS No.:2216712-66-0?

There are several reasons why Elexacaftor CAS No.:2216712-66-0 is the best choice for treating cystic fibrosis:

1. Effective: The medicine has been proven to be highly effective in treating cystic fibrosis. It has been tested in clinical trials and has shown significant improvements in lung function and quality of life for patients with cystic fibrosis.

2. Safe: Elexacaftor CAS No.:2216712-66-0 has been tested extensively and has been found to be safe for use in patients with cystic fibrosis. It has been approved by regulatory authorities in various countries and has been prescribed to thousands of patients worldwide.

3. Easy to Use: Elexacaftor CAS No.:2216712-66-0 is available in the form of tablets, which can be taken orally. This makes it easy for patients to take the medicine at home without having to visit a healthcare facility.

4. Affordable: Our company offers Elexacaftor CAS No.:2216712-66-0 at a competitive price. This makes it affordable for patients who need the medicine but may not be able to afford other expensive treatments.

Conclusion:

Elexacaftor CAS No.:2216712-66-0 is a breakthrough product for treating cystic fibrosis. It is effective, safe, easy to use, and affordable, making it the best choice for patients with cystic fibrosis. Our company is committed to providing high-quality and affordable products to our customers, and we are confident that Elexacaftor CAS No.:2216712-66-0 will exceed your expectations. We welcome inquiries from merchants interested in purchasing our product and are happy to answer any questions you may have.

Chemical Structure : Elexacaftor

CAS No.: 2216712-66-0

 

Elexacaftor((VX-445, WHO11180)

Catalog No.: URK-V1555 Only Used For Lab.

Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector and modulator for cystic fibrosis treatment.

Biological Activity

Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector and modulator for cystic fibrosis treatment.

Physicochemical Properties

References

1. Keating D, et al. N Engl J Med. 2018 Oct 25;379(17):1612-1620.

2. Taylor-Cousar JL, et al. ERJ Open Res. 2019 Jun 17;5(2):00082-2019.

3. Middleton PG, et al. N Engl J Med. 2019 Nov 7;381(19):1809-1819.

URK-V1555_COA

URK-V1555_SDS

URK-V1555_TDS

 

Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!

Why choose us?

• We offer a wide selection of Membrane Transporter/Ion Channel Library products to meet the diverse needs of our customers.
• We are based on both domestic and international markets and actively develop new products that are marketable.
• Our Membrane Transporter/Ion Channel Library products are known for their precision and accuracy, providing reproducible results.
• All along, our company has been innovating Elexacaftor CAS No.:2216712-66-0, expanding production scale, establishing its own brand, and constantly improving its brand image.
• We have a strong commitment to customer satisfaction and strive to deliver exceptional Membrane Transporter/Ion Channel Library products and customer service.
• Our company has established a patent award mechanism to mobilize the enthusiasm of the staff to participate in invention and creation.
• Our company is committed to offering top-quality Membrane Transporter/Ion Channel Library products at affordable prices.
• We provide equal and broad promotion platform for our employees, which provides a strong guarantee for the enterprise to be invincible in the fierce competition.
• We work tirelessly to ensure that our Membrane Transporter/Ion Channel Library products meet and exceed industry standards.
• The company is willing to work with you towards a win-win situation with advanced technology, stable product quality, perfect after-sales service and honest business philosophy, and continue to provide better products and services to Chinese and global customers.

Hot Tags: elexacaftor cas no.:2216712-66-0, China elexacaftor cas no.:2216712-66-0, agonists for antibody therapy, inhibitors for histone modification, epigenetic library for epigenetic genotype, epigenetic library for epigenetic suppression, epigenetic library for epigenetic analysis of epigenetic editing, inhibitors for scar formation